Data Foundry

Drug recalls 2026

Abirtega — Class II drug recall D-0076-2027

Ongoing recall by Hikma Pharmaceuticals USA INC., reported 2026-10-28, distributed nationwide. Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Recall numberD-0076-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmHikma Pharmaceuticals USA INC., Columbus, OH, United States
Recall initiated2026-10-06
Classified2026-10-23
Reported by FDA2026-10-28
DistributedNationwide (US)
Quantity2,136 bottles
NDC82249-0011, 82249-0011-12
Lot numbers3047
Expiration dates2027-07-20

Product

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Reason for recall

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0076-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-03. Not affiliated with or endorsed by FDA. Not medical or legal advice.